Trieste, Italy

Elisabetta Chiellini

USPTO Granted Patents = 2 

 

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Elisabetta Chiellini: Innovator in Pharmaceutical Emulsions

Introduction

Elisabetta Chiellini is a prominent inventor based in Trieste, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative microemulsion formulations. With a total of 2 patents, her work focuses on enhancing the stability and efficacy of drug delivery systems.

Latest Patents

Chiellini's latest patents include a pharmaceutical microemulsion designed to prevent supramolecular aggregation of amphiphilic molecules. This invention addresses the issue of hypersensitivity reactions and other unwanted side effects associated with amphiphilic drug molecules. Another notable patent is for ophthalmic oil-in-water emulsions containing prostaglandins. This formulation is intended for ophthalmic applications and includes a combination of non-ionic surfactants, ensuring increased chemical stability of the prostaglandin active agent for long-term storage, even at room temperature.

Career Highlights

Elisabetta Chiellini is currently associated with Azad Pharma AG, where she continues to innovate in the pharmaceutical sector. Her work has been instrumental in advancing drug formulations that improve patient outcomes and safety.

Collaborations

Chiellini collaborates with esteemed colleagues such as Fabio Carli and Mihran Baronian, contributing to a dynamic research environment that fosters innovation.

Conclusion

Elisabetta Chiellini's contributions to pharmaceutical emulsions exemplify her commitment to improving drug delivery systems. Her innovative patents reflect her expertise and dedication to advancing medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…